MA
TECH icon

Modus Advisors’s Bio-Techne TECH Stock Holding History

Modus Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,770
Closed -$344K – 283
2024
Q4 		$344K Hold
4,770
– – 0.11% 96
2024
Q3 		$381K Sell
4,770
-100
-2% -$7.51K 0.13% 96
2024
Q2 		$349K Sell
4,870
-100
-2% -$7.36K 0.12% 92
2024
Q1 		$350K Buy
+4,970
New +$356K 0.13% 90
2022
Q1 		– Sell
-1,760
Closed -$228K – 102
2021
Q4 		$228K Hold
1,760
– – 0.1% 93
2021
Q3 		$213K Hold
1,760
– – 0.09% 96
2021
Q2 		$198K Buy
+1,760
New +$185K 0.08% 96
2020
Q3 		– Sell
-1,840
Closed -$121K – 194
2020
Q2 		$121K Buy
+1,840
New +$110K 0.08% 87

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Modus Advisors's TECH Position: Q1 2025 in Review

Modus Advisors sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 4,770 shares — an estimated $344K sold.

Modus Advisors first reported a position in TECH in Q2 2020 and held it in 8 quarters. The position peaked at $381K in Q3 2024. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Modus Advisors reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Modus Advisors sold 4,770 Bio-Techne shares in Q1 2025, an estimated $344K.
  • Modus Advisors first reported a position in Bio-Techne in Q2 2020 and held it in 8 quarters.
  • Modus Advisors's Bio-Techne position peaked at $381K in Q3 2024.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Modus Advisors's 13F filing for Q1 2025, filed 1 Apr 2025.